Select Page

Aristo Biotech and Life Science IPO GMP, Price, Dates & Allotment Details 2023

Aristo Biotech and Life Science IPO GMP, Price, Dates & Allotment Details 2023

Aristo Biotech & Life Sciences IPO will open on January 16 and close on January 19, 2023. As per the DRHP filed with SEBI, the company intends to raise approximately ₹ 13.05 crore through this public offering, consisting of 1,812,800 shares of face value of ₹ 10 each. Which will be issued at a price of ₹ 72 per share.

Incorporated in 2005. Company is an agrochemical company engaged in the manufacturing, formulation, supplying, packaging, and job work services of various pesticides such as insecticides, herbicides, fungicides, plant growth regulators, and a variety of other agrochemicals for India as well as for export.
Agrochemical industries are a very diversified field and deal with the production and distribution of pesticides and fertilisers to increase crop yields. Pesticides and agrochemicals (sometimes known as crop protection products or pesticides) are used to protect crops against weeds, insects, and illnesses. Currently, the company has 182 products registered with CIB & RC for manufacturing and sales.
It is an ISO 9001:2015-certified company for its quality management system. The company’s diversified product portfolio can be classified as herbicides, weedicides, fungicides, plant growth regulators, and insecticides. It sells its goods in 20 Indian states and 15 other countries.

Objects of the Issue

The company proposes to utilize the net proceeds of the Fresh Issue towards funding the following objects:

  1. To Meet Working Capital Requirement
  2. General Corporate Purpose
  3. To Meet the Issue Expenses

Financial Highlights (Consolidated)

ParticularsPeriod ended on 30th September 2022FY 2021-22FY 2020-21FY 2019-20
Net Worth1743.151484.251338.081230.51
Total Assets10869.147700.168141.738785.12
Total Revenue12907.4916603.2916722.9620123.94
Profit After Tax258.90146.17107.57100.74
(Amount in ₹ Lakhs)

ALSO READ

Best Stock To Buy During Covid Pandemic 

As you must be seeing in the news right now, the Covid pandemic is knocking again in the world. We have seen earlier that the impact of the Covid epidemic falls on every sector of the economy. READ MORE

Aristo Biotech and Life Science IPO – Details

According to the DRHP filed with SEBI, the company plans to issue 1,812,800 shares of face value of ₹ 10 each, aggregating up to ₹ 13.05 crore.

Issue TypeFixed Price Issue IPO
IPO Price₹ 72 per share
Face Value₹ 10 per share
Market Lot1,600 shares
Issue Size1,812,800 shares of ₹ 10 (Aggregating up to ₹ 13.05 Crore)
Fresh Issue1,812,800 shares of ₹ 10 (Aggregating up to ₹ 13.05 Crore)
NII (HNI) Shares Offered50% of the Net Issue
Retail Shares Offered50% of the Net Issue
Listing AtNSE SME
Promoters1. Mr. Narendra Singh Barhat, 
2. Mrs. Kusum Narendra Singh Barhat 
3. Mr. Ketankumar Harkantbhai Joshi

GMP – Aristo Biotech and Life Science IPO

Aristo Biotech and Life Science IPO GMP, or Grey Market Premium, are available here. The IPO GMP Premium updated day by day for IPOs’ running periods, and the GMP rates fluctuate and became stable some time later. The GMP rates are not 100% guaranteed. Please click here for GMP details.

Tentative Dates – Aristo Biotech and Life Science IPO

Aristo Biotech and Life Science IPO opens on January 16 and closes on January 19, 2023.

Opening DateJanuary 16, 2023
Closing DateJanuary 19, 2023
Basis of AllotmentJanuary 24, 2023
Initiation of RefundsJanuary 15, 2023
Credit of shares to Demat A/cJanuary 26, 2023
Listing DateJanuary 27, 2023

Lot Size – Aristo Biotech and Life Science IPO

The Aristo Biotech and Life Science IPO lot size is 1,600 shares. A retail-individual investor can apply for up to 1 lot i.e. 1,600 shares of ₹ 115,200.

ApplicationsLotsSharesAmount 
Retail (Minimum)11,600₹ 115,200
Retail (Maximum)11,600₹ 115,200
HNI (Minimum)23,200₹ 230,400

Promoters Holdings – Aristo Biotech and Life Science IPO

Pre-issue Shares Holdings100%
Post-issue Shares Holdings73.37%

ALSO READ

Glenmark Pharmaceuticals Limited Share Price Targets 2023, 2024, 2025, 2026, 2028, 2030 & 2040

This post is about Glenmark Pharmaceuticals Ltd.’s share price targets in the coming years. India has the most pharmaceutical manufacturing facilities. The Indian Pharmaceutical Industry READ MORE

SWOT Analysis – Aristo Biotech and Life Science IPO

STRENGTHSWEAKNESSES
1. Existing client relationship.
2. Quality Assurance and Standards.
3. Scalable Business Model.
4. Cost effective production and timely fulfillment of orders.
1. There are outstanding legal proceedings involving the company, directors, and promoters.
2. Climate conditions and cyclicality affect the Aristo Biotech and Life Science business. 
2. The company’s top 10 customers contribute the majority of its revenues.
OPPORTUNITIESTHREATS
1. A rise in agricultural demand is propelling the growth of agrochemicals in India. 
2. The Indian chemicals industry was worth US$ 178 billion in 2019 and is expected to be worth US$ 304 billion by 2025, growing at a 9.3% CAGR. 
3. The demand for chemicals is expected to expand by 9% per year by 2025.

1. Company failure to adapt to technological development or industry trends.
2. Competitions from organized and unorganized players.

Miscellaneous Information

Download Prospectus (PDF)IPO DRHP
IPO RHP
Company Contact InformationAristo Bio-Tech and Life Science Limited
E-24,25,26, G.I.D.C. Manjusar, Ta. Savli, Vadodara – 391775
Phone: +91-2667-264843
Email: [email protected]
Website: http://www.aristobiotech.com/
IPO RegistrarLink Intime India Private Ltd
Phone: +91-22-4918 6270
Email: [email protected]
Website: https://linkintime.co.in/
IPO Lead Manager(s)Beeline Capital Advisors Pvt Ltd 

FAQ’s

The Aristo Biotech and Life Science IPO price is ₹ 72 per share.

One lot of Aristo Biotech and Life Science IPO contains 1,600 shares of ₹ 115,200.

The minimum investment size is one lot for retail investors.

The Aristo Biotech and Life Science IPO shares listing date is January 27, 2023.

The investors’ portion for NII (HNI) – 50%, and Retail – 50%.

Click here for more FAQs.

Leave a reply

Your email address will not be published. Required fields are marked *

Current IPO (Main Board)

Issuer CompanyOpenClose
Tata Technologies Ltd.--
Plaza Wires Ltd.29-Sep-234-Oct-23
27-Sep-233-Oct-23
Updater Services Ltd.25-Sep-2327-Sep-23
JSW Infrastructure ltd.25-Sep-2327-Sep-23
22-Sep-2326-Sep-23
20-Sep-2322-Sep-23
20-Sep-2322-Sep-23
Yatra Online Ltd.15-Sep-2320-Sep-23
14-Sep-2318-Sep-23

SME IPO

Issuer CompanyOpenClose
Rajgor Castor Derivatives Ltd.17-Oct-2320-Oct-23
WomanCart Ltd.16-Oct-2318-Oct-23
12-Oct-2316-Oct-23
Committed Cargo Care Ltd.6-Oct-2310-Oct-23
29-Sep-234-Oct-23
Karnika Industries Ltd.29-Sep-234-Oct-23
Plada Infotech Services Ltd.29-Sep-234-Oct-23
29-Sep-234-Oct-23
29-Sep-234-Oct-23
Vivaa Tradecom Ltd.27-Sep-234-Oct-23

RECENT COMMENT